Colonial Trust Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-177
| Closed | -$16.8K | – | 1033 |
|
|
2024
Q1 | $16.8K | Buy |
+177
| New | +$16.8K | ﹤0.01% | 506 |
|
|
2022
Q1 | – | Sell |
-6,024
| Closed | -$674K | – | 189 |
|
|
2021
Q4 | $674K | Sell |
6,024
-730
| -11% | -$81.7K | 0.08% | 124 |
|
|
2021
Q3 | $849K | Sell |
6,754
-355
| -5% | -$44.6K | 0.1% | 112 |
|
|
2021
Q2 | $963K | Buy |
7,109
+1,465
| +26% | +$198K | 0.12% | 111 |
|
|
2021
Q1 | $766K | Buy |
5,644
+1,535
| +37% | +$208K | 0.1% | 118 |
|
|
2020
Q4 | $578K | Buy |
4,109
+1,125
| +38% | +$158K | 0.08% | 121 |
|
|
2020
Q3 | $333K | Buy |
2,984
+761
| +34% | +$84.9K | 0.05% | 136 |
|
|
2020
Q2 | $249K | Buy |
+2,223
| New | +$249K | 0.04% | 141 |
|